Nutra Pharma Corp (NPHC) Other Non-Current Liabilities (2010 - 2026)

Nutra Pharma has disclosed Other Non-Current Liabilities across 12 years of filings, most recently posting $52800.0 for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $52800.0; the TTM figure through Jun 2026 stood at $52800.0 (changed 0.0% YoY), while the FY2025 annual figure was $52800.0, changed 0.0% from the prior year.
• Other Non-Current Liabilities came in at $52800.0 for Q2 2026 at Nutra Pharma, roughly flat from $52800.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $52800.0 in Q3 2023 to a low of $35200.0 in Q4 2023.
• Average Other Non-Current Liabilities over 4 years is $51333.3, with a median of $52800.0 recorded in 2023.
• The largest YoY upside for Other Non-Current Liabilities was 50.0% in 2024 against a maximum downside of 0.0% in 2024.
• Over 4 years, Other Non-Current Liabilities stood at $35200.0 in 2023, then surged by 50.0% to $52800.0 in 2024, then changed by 0.0% to $52800.0 in 2025, then changed by 0.0% to $52800.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $52800.0 in Q2 2026, $52800.0 in Q1 2026, and $52800.0 in Q4 2025.